Challenges associated with metal chelation therapy in Alzheimer's disease - Wikidata - awgldk - TriplyDB

Challenges associated with metal chelation therapy in Alzheimer's disease

Challenges associated with metal chelation therapy in Alzheimer's disease

http://www.wikidata.org/entity/Q34099450

about

Chelation for autism spectrum disorder (ASD)Chelation for autism spectrum disorder (ASD)Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels New perspectives on oxidized genome damage and repair inhibition by pro-oxidant metals in neurological diseases Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies Clioquinol inhibits zinc-triggered caspase activation in the hippocampal CA1 region of a global ischemic gerbil model The native copper- and zinc-binding protein metallothionein blocks copper-mediated Abeta aggregation and toxicity in rat cortical neurons.The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice Neuronutrition and Alzheimer's disease Specific Inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases.The role of chelation in the treatment of other metal poisonings.Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases.The effect of green tea extract supplementation on sputum smear conversion and weight changes in pulmonary TB patients: A randomized controlled trial Oxidative genome damage and its repair in neurodegenerative diseases: function of transition metals as a double-edged sword.Novel 8-Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer's Disease.Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?Increased non-protein bound iron in Down syndrome: contribution to lipid peroxidation and cognitive decline.Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.An N-heterocyclic amine chelate capable of antioxidant capacity and amyloid disaggregation.Copper and Alzheimer's Disease.Phenolic content, antioxidant and enzyme inhibitory capacity of two Trametes species

P2860

Q24187986-1AC256C4-1CB3-4D81-9FB9-03A232D334C1 Q24197842-A1EBEE18-492B-4846-A82E-629C35F6A72A Q24289511-DA149118-25A8-46B2-A7B1-F937EAF5F9CF Q26751302-9945B973-01A9-4774-83AF-E767C5F58AE7 Q26996127-B5426B6E-45A5-499B-86CA-2C4E0241476D Q28307760-27E81258-EE99-46FE-A457-5E5DC0FCCC75 Q28483048-89C3655D-19D8-4770-A604-1AC624426AFA Q33649794-448251FE-8892-4FCB-B736-E83EF9D239C0 Q33658827-AFA71299-2D5E-4090-88EA-00CD4CD9F108 Q34065923-A6CB7882-AE1A-4E0E-81C6-3F3F343AFF0C Q34099466-E80BFEAF-EF7B-4F00-88B0-01B2E78AB1A6 Q34121351-1BC66CB0-8C92-499C-800D-020B4C36F9E9 Q34376795-BB8B3D92-B625-4819-AC8E-B8BD976CFC7D Q35957287-3874943F-592B-4428-A82E-EAE9ED4233F6 Q37149316-6D14F0C6-A975-436D-9E11-21D48F8D69C7 Q37858347-AE15D9E4-5E14-4507-B521-E4E87B569005 Q38793949-EA8AF128-957E-4560-8ABB-773F5FAF5607 Q38963019-31B313C3-71F6-4646-BDB2-2E0BF4D89BAB Q39244955-7AF94479-E11A-4081-8605-2F333AF141A9 Q41229397-0AE7D11F-F857-406E-840B-DB4CEC7C09D8 Q41671303-2F83471F-EEFC-4700-9225-E3AC35E21500 Q46309586-422005C2-109B-4AC8-9397-24D6DB54CDB6 Q58870432-94680790-CCF6-4A38-A1CD-6D0501D11E78

P2860

Challenges associated with metal chelation therapy in Alzheimer's disease

http://www.wikidata.org/entity/Q34099450

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Challenges associated with metal chelation therapy in Alzheimer's disease

@ast

Challenges associated with metal chelation therapy in Alzheimer's disease

@en

Challenges associated with metal chelation therapy in Alzheimer's disease

@nl

type

label

Challenges associated with metal chelation therapy in Alzheimer's disease

@ast

Challenges associated with metal chelation therapy in Alzheimer's disease

@en

Challenges associated with metal chelation therapy in Alzheimer's disease

@nl

prefLabel

Challenges associated with metal chelation therapy in Alzheimer's disease

@ast

Challenges associated with metal chelation therapy in Alzheimer's disease

@en

Challenges associated with metal chelation therapy in Alzheimer's disease

@nl

P1433

Q34099450-C5306F23-DBCE-4E2D-8746-C8F1D55C72C6

P1476

Q34099450-7C94C04B-C7F5-4779-B850-93D2FB8975C4

P2093

Q34099450-2565E26A-7DA5-4778-A5F1-B0D0BBF64301

Q34099450-45C72D6C-24EC-42B9-9ED7-211045843BDB

Q34099450-6C07F4C4-2ED7-418B-8EFE-F60784F892A7

Q34099450-8750DDB4-406B-4EFB-82C4-37E3902D924C

Q34099450-87F82DE8-23CB-43F9-8CD4-793E72644F1F

Q34099450-8ABFFB3A-0B36-4656-8130-ED27250161DD

Q34099450-A1C211E1-D033-4BA8-8C66-FFFA93D3AD10

Q34099450-ABB79CC8-C85A-41A8-AC72-FE09055BA7C8

Q34099450-C678BDB4-1ACF-4218-B88F-69B900EA9B25

Q34099450-F0047C77-E80F-4557-80DC-3E152AE35C0B

P2860

Q34099450-001CB7B5-B70B-4E68-B83A-0C0ACDA471D3

Q34099450-020B416A-3202-4212-A720-646FDFD4E9C0

Q34099450-0669C9B0-1DAB-42BA-B353-71EA5BE75330

Q34099450-09821847-50B8-4736-9C04-3E8675A458CE

Q34099450-0B184C74-A1E4-4F08-82DA-397403738907

Q34099450-0BDDA533-E52C-4357-93F1-D883C715B827

Q34099450-0DC2192C-8394-4C61-917E-C3D11632CADB

Q34099450-1012925E-CB65-4325-8061-CF590144FB76

Q34099450-136F00D7-5D28-4005-A9E2-CF7728A634AD

Q34099450-14819744-5959-4B16-80C9-CF7A9B53E894

P304

Q34099450-F8351D75-2B98-4A55-AAED-1E7CFF8986A8

P31

Q34099450-231759FE-AF09-45A2-9F8D-E06EAB1C69C9

P356

Q34099450-0EF9694D-EE6E-4D89-9677-A5C2D67A3311

P433

Q34099450-D3966711-FE60-4696-8911-61A394046E8F

P478

Q34099450-F1D62D54-1506-4558-974F-6A5F194EEED8

P50

Q34099450-5AC56DAF-8431-433A-A482-8758C93AC162

Q34099450-6C0555D9-6AD5-4385-A0CF-CA0C71C6DA75

Q34099450-FF724417-E7FA-4703-9684-DF5C7147E5BA

P577

Q34099450-4CCC367E-70BE-46B8-BBA9-8AF96DB23107

P698

Q34099450-50EE0894-0E88-44A2-85B2-1621C2734F53

P921

Q34099450-E548B58C-CC07-41CB-8114-C6F882D63D3D

Q34099450-d6b88981-e794-4376-a614-2f5ed2d6314f

P932

Q34099450-6549529E-BEEB-4AF4-A620-EBFB8EBE5E46

P356

P1433

Journal of Alzheimer's Disease

P1476

Challenges associated with metal chelation therapy in Alzheimer's disease

@en

P2093

Anitha Suram

http://www.w3.org/2001/XMLSchema#string

Chitra Venugopal

http://www.w3.org/2001/XMLSchema#string

Janez Scancar

http://www.w3.org/2001/XMLSchema#string

Kosagisharaf Jagannatha Rao

http://www.w3.org/2001/XMLSchema#string

Luigi Zecca

http://www.w3.org/2001/XMLSchema#string

P Bharathi

http://www.w3.org/2001/XMLSchema#string

Pankaj Poddar

http://www.w3.org/2001/XMLSchema#string

Paolo Zatta

http://www.w3.org/2001/XMLSchema#string

Pullabhatla Srinivas

http://www.w3.org/2001/XMLSchema#string

Ramya Jagannathan

http://www.w3.org/2001/XMLSchema#string

P2860

Metals, toxicity and oxidative stress

Oxidative mechanisms in the toxicity of metal ions

Iron, brain ageing and neurodegenerative disorders

Alzheimer's disease

Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions.

Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain.

Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study.

Transgenic animals relevant to Alzheimer's disease.

Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Chelation therapy for coronary heart disease: An overview of all clinical investigations.

P304

457-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2009-1068

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Muralidhar L. Hegde

Kumar Sambamurti

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19363258

http://www.w3.org/2001/XMLSchema#string

P921

chelation therapy

Alzheimer's disease

P932

2931820

http://www.w3.org/2001/XMLSchema#string